ATE402691T1 - Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung - Google Patents

Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung

Info

Publication number
ATE402691T1
ATE402691T1 AT03008447T AT03008447T ATE402691T1 AT E402691 T1 ATE402691 T1 AT E402691T1 AT 03008447 T AT03008447 T AT 03008447T AT 03008447 T AT03008447 T AT 03008447T AT E402691 T1 ATE402691 T1 AT E402691T1
Authority
AT
Austria
Prior art keywords
oral
pharmaceutical compositions
topical administration
topical
administration
Prior art date
Application number
AT03008447T
Other languages
English (en)
Inventor
Tomas Andrysek
Milan Stuchlik
Ales Vrana
Alexander Jegorov
Josef Stuchlik
Vladimir Matha
Original Assignee
Ivax Pharmaceuticals Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE402691(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Pharmaceuticals Sro filed Critical Ivax Pharmaceuticals Sro
Application granted granted Critical
Publication of ATE402691T1 publication Critical patent/ATE402691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
AT03008447T 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung ATE402691T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration

Publications (1)

Publication Number Publication Date
ATE402691T1 true ATE402691T1 (de) 2008-08-15

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00951765T ATE288766T1 (de) 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
AT03008447T ATE402691T1 (de) 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00951765T ATE288766T1 (de) 1999-08-17 2000-08-17 Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung

Country Status (40)

Country Link
US (1) US20070190132A1 (de)
EP (2) EP1334717B1 (de)
JP (2) JP2003507343A (de)
KR (2) KR100828748B1 (de)
CN (2) CN1382061A (de)
AR (2) AR025324A1 (de)
AT (2) ATE288766T1 (de)
AU (1) AU777740B2 (de)
BR (1) BR0013385A (de)
CA (2) CA2452118A1 (de)
CO (1) CO5380014A1 (de)
CY (1) CY1105318T1 (de)
CZ (2) CZ296170B6 (de)
DE (2) DE60018081T2 (de)
DK (2) DK1334717T3 (de)
EE (2) EE04955B1 (de)
EG (1) EG23994A (de)
ES (2) ES2237443T3 (de)
GB (1) GB2355656B (de)
HK (1) HK1049629A1 (de)
HR (1) HRP20020154B1 (de)
HU (1) HUP0203236A3 (de)
IL (4) IL158108A0 (de)
JO (1) JO2324B1 (de)
MX (1) MXPA02001631A (de)
NO (2) NO20020760L (de)
NZ (1) NZ517271A (de)
PE (1) PE20010636A1 (de)
PL (1) PL192769B1 (de)
PT (2) PT1210119E (de)
RU (2) RU2279894C2 (de)
SA (1) SA00210487B1 (de)
SG (1) SG143019A1 (de)
SI (1) SI1210119T1 (de)
SK (2) SK2482002A3 (de)
TN (1) TNSN00173A1 (de)
UA (2) UA72539C2 (de)
UY (1) UY26303A1 (de)
WO (1) WO2001012229A1 (de)
ZA (2) ZA200308221B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (de) * 2002-12-03 2008-06-25 Elan Pharma International Limited Formen zur Dosierung einer Flüssigkeit mit geringer Viskosität
EP1582206A4 (de) * 2002-12-04 2010-09-22 Nisshin Pharma Inc Wasserlösliche zusammensetzung mit coenzym q10
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
EP3470084A1 (de) 2002-12-09 2019-04-17 Abraxis BioScience, LLC Zusammensetzungen enthaltend albuminnanopartikel und methoden zur freisetzung von wirkstoffen
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
US20060188566A1 (en) * 2005-02-24 2006-08-24 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
WO2010060798A1 (en) * 2008-11-28 2010-06-03 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
CA2752713C (en) * 2009-03-12 2017-01-03 Advance Holdings Limited Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
JP6763939B2 (ja) * 2015-03-27 2020-09-30 アーチ・パーソナル・ケア・プロダクツ・エルピー パーソナルケア製品のための粘度増強組成物
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
EP0973502A1 (de) * 1997-03-12 2000-01-26 Abbott Laboratories Lipophile binärsystemen für die verarbreichung von lipophile komponenten
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
DE69823663T2 (de) * 1997-07-29 2005-05-19 Pharmacia & Upjohn Co., Kalamazoo Selbstemulgierbare formulierung enthaltend lipophile verbindungen
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
ES2237443T3 (es) 2005-08-01
EE200300371A (et) 2003-10-15
NO20020760D0 (no) 2002-02-15
DE60018081D1 (de) 2005-03-17
IL158108A0 (en) 2004-03-28
RU2279894C2 (ru) 2006-07-20
EP1334717A2 (de) 2003-08-13
CZ296170B6 (cs) 2006-01-11
TNSN00173A1 (en) 2005-11-10
IL148200A0 (en) 2002-09-12
SK2482002A3 (en) 2002-12-03
PL192769B1 (pl) 2006-12-29
IL158108A (en) 2010-04-15
GB9919288D0 (en) 1999-10-20
DK1210119T3 (da) 2005-06-20
RU2003133451A (ru) 2005-04-20
MXPA02001631A (es) 2003-07-14
ZA200308221B (en) 2004-09-29
DK1334717T3 (da) 2008-11-24
UA75926C2 (en) 2006-06-15
WO2001012229A1 (en) 2001-02-22
PE20010636A1 (es) 2001-06-02
EP1210119B1 (de) 2005-02-09
DE60322454D1 (de) 2008-09-11
EE04955B1 (et) 2008-02-15
PL353445A1 (en) 2003-11-17
SG143019A1 (en) 2008-06-27
GB2355656B (en) 2004-04-07
GB2355656A (en) 2001-05-02
SI1210119T1 (en) 2005-06-30
DE60018081T2 (de) 2006-01-05
NO20020760L (no) 2002-04-16
EE04954B1 (et) 2008-02-15
EG23994A (en) 2008-03-10
US20070190132A1 (en) 2007-08-16
PT1334717E (pt) 2008-10-09
PT1210119E (pt) 2005-05-31
AR025324A1 (es) 2002-11-20
CN101406453A (zh) 2009-04-15
AU777740B2 (en) 2004-10-28
HK1049629A1 (zh) 2003-05-23
NZ517271A (en) 2004-02-27
JP2004238399A (ja) 2004-08-26
HUP0203236A2 (hu) 2003-01-28
AU6461300A (en) 2001-03-13
KR20020059367A (ko) 2002-07-12
KR20050095651A (ko) 2005-09-29
ZA200201315B (en) 2004-06-30
CN1382061A (zh) 2002-11-27
KR100828748B1 (ko) 2008-05-09
ES2311077T3 (es) 2009-02-01
JO2324B1 (en) 2005-09-12
CA2452118A1 (en) 2001-02-22
HRP20020154B1 (en) 2006-07-31
RU2279895C2 (ru) 2006-07-20
EP1210119A1 (de) 2002-06-05
CA2380951C (en) 2010-03-23
IL148200A (en) 2007-12-03
NO20034778D0 (no) 2003-10-24
HRP20020154A2 (en) 2003-12-31
JP2003507343A (ja) 2003-02-25
SK286083B6 (sk) 2008-03-05
SA00210487B1 (ar) 2006-09-10
AR043106A2 (es) 2005-07-20
CA2380951A1 (en) 2001-02-22
UY26303A1 (es) 2001-03-16
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
CZ2002575A3 (cs) 2003-05-14
HUP0203236A3 (en) 2004-06-28
EP1334717B1 (de) 2008-07-30
ATE288766T1 (de) 2005-02-15
BR0013385A (pt) 2002-05-07
CO5380014A1 (es) 2004-03-31
EP1334717A3 (de) 2004-01-02
UA72539C2 (en) 2005-03-15
CY1105318T1 (el) 2010-03-03
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15

Similar Documents

Publication Publication Date Title
DE60018081D1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
DE60317803D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
ATE279927T1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
EP1188440A4 (de) Medizinische zusammensetzungen zur oralen verabreichung
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
GB0014474D0 (en) Pharmaceutical formulation and manufacture of oral dosage units
SE9904414D0 (sv) Pharmaceutical composition and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334717

Country of ref document: EP